Related Experiment Video
Updated: Jan 31, 2026
Detection of Targetable Alterations in Non-small Cell Lung Cancer using Next-generation Sequencing
Published on: October 10, 2025
Predicting drug susceptibility of non-small cell lung cancers based on genetic lesions
Martin L Sos1, Kathrin Michel, Thomas Zander
1Max Planck Institute for Neurological Research, Klaus-Joachim-Zülch Laboratories of Max Planck Society, and University of Köln Medical Faculty, University of Köln, Cologne, Germany.
Abstract:
Somatic genetic alterations in cancers have been linked with response to targeted therapeutics by creation of specific dependency on activated oncogenic signaling pathways. However, no tools currently exist to systematically connect such genetic lesions to therapeutic vulnerability. We have therefore developed a genomics approach to identify lesions associated with therapeutically relevant oncogene dependency. Using integrated genomic profiling, we have demonstrated that the genomes of a large panel of human non-small cell lung cancer (NSCLC) cell lines are highly representative of those of primary NSCLC tumors. Using cell-based compound screening coupled with diverse computational approaches to integrate orthogonal genomic and biochemical data sets, we identified molecular and genomic predictors of therapeutic response to clinically relevant compounds. Using this approach, we showed that v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog (KRAS) mutations confer enhanced Hsp90 dependency and validated this finding in mice with KRAS-driven lung adenocarcinoma, as these mice exhibited dramatic tumor regression when treated with an Hsp90 inhibitor. In addition, we found that cells with copy number enhancement of v-abl Abelson murine leukemia viral oncogene homolog 2 (ABL2) and ephrin receptor kinase and v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) (SRC) kinase family genes were exquisitely sensitive to treatment with the SRC/ABL inhibitor dasatinib, both in vitro and when it xenografted into mice. Thus, genomically annotated cell-line collections may help translate cancer genomics information into clinical practice by defining critical pathway dependencies amenable to therapeutic inhibition.
Insights
This study developed a genomics approach to link cancer genetic alterations to targeted therapy vulnerabilities. Researchers identified KRAS mutations enhancing Hsp90 dependency and SRC/ABL gene amplification predicting sensitivity to dasatinib.
Area of Science:
- Oncology
- Genomics
- Pharmacology
Background:
- Somatic genetic alterations in cancer can create dependencies on specific oncogenic signaling pathways, influencing targeted therapy response.
- Currently, no systematic tools exist to connect genetic lesions with therapeutic vulnerabilities.
- Non-small cell lung cancer (NSCLC) cell lines can serve as representative models for primary NSCLC tumors.
Purpose of the Study:
- To develop a genomics approach to identify genetic lesions linked to therapeutically relevant oncogene dependencies.
- To discover molecular and genomic predictors of therapeutic response to clinically relevant compounds in NSCLC.
- To translate cancer genomics findings into clinical practice by defining actionable pathway dependencies.
Main Methods:
- Integrated genomic profiling of a large panel of human NSCLC cell lines.
- Cell-based compound screening and computational approaches to integrate genomic and biochemical data.
- Validation of identified dependencies in preclinical models (cell lines and mice).
Main Results:
- v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog (KRAS) mutations were found to confer enhanced Hsp90 dependency, leading to tumor regression in mice upon Hsp90 inhibitor treatment.
- Copy number enhancement of v-abl Abelson murine leukemia viral oncogene homolog 2 (ABL2) and SRC kinase family genes predicted exquisite sensitivity to the SRC/ABL inhibitor dasatinib in vitro and in vivo.
- Established a link between specific genetic alterations and drug sensitivity, demonstrating predictive power.
Conclusions:
- Genomically annotated cell-line collections are valuable for identifying critical pathway dependencies.
- This approach can help translate cancer genomics discoveries into clinical applications for targeted therapies.
- The study provides a framework for connecting genetic lesions to therapeutic vulnerabilities in cancer.
More Related Videos
Related Concept Videos
02:27Predicting Molecular Geometry
01:31Magnetic Susceptibility and Permeability
When diamagnetic materials are placed under an external magnetic field, the moments opposite to the field are induced. Hence, the susceptibility for diamagnets has a minimal negative value of 10-5–10-6. Since...
01:47Lung Capacity
01:03Prediction Intervals
However, the point estimate is most likely not the exact value of the population parameter, but close to it. After calculating point estimates, we construct interval estimates, called confidence intervals or prediction intervals. This prediction interval comprises a range of values unlike the point estimate and is a better predictor of the observed sample value, y.
02:16Genetics of Speciation
02:59Animal Mitochondrial Genetics